Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-18

FDA Approved: FENTANYL SYSTEM — Supplemental Application (ALVOGEN)

View source ↗

Summary

FDA approved a supplemental application for the Fentanyl System by ALVOGEN, indicating continued authorization for this fentanyl transdermal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL SYSTEM (FENTANYL)

Snippet

SUPPL AP for FENTANYL SYSTEM (FENTANYL)